GCIA
RCEL icon

Gabelli & Co Investment Advisers’s Avita Medical RCEL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$106K – 315
2025
Q2 		$106K Buy
+20,000
New +$145K 0.02% 226

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Gabelli & Co Investment Advisers's RCEL Position: Q3 2025 in Review

Gabelli & Co Investment Advisers sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 20,000 shares — an estimated $106K sold.

Gabelli & Co Investment Advisers first reported a position in RCEL in Q2 2025 and held it in 1 quarter. The position peaked at $106K in Q2 2025. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Gabelli & Co Investment Advisers reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 20,000 Avita Medical shares in Q3 2025, an estimated $106K.
  • Gabelli & Co Investment Advisers first reported a position in Avita Medical in Q2 2025 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Avita Medical position peaked at $106K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.